Featured Research

from universities, journals, and other organizations

DNA mutation rates raise curtain on cause of cancer

Date:
July 1, 2010
Source:
Brandeis University
Summary:
What if we could understand why cancer develops? One idea that has emerged is that for a cell to transform into a cancer cell it must suffer a large number of mutations affecting different genes needed to control cell growth. Researchers have found that the process of repairing DNA damage also unexpectedly increases the rate of mutations and changes the kinds of mutations that arise.

What if we could understand why cancer develops? We know that certain risk factors, such as smoking or excessive sun exposure, can increase the chances of developing this terrible disease, but cancer can form in any tissue, and the cause is not always clear. One idea that has emerged is that for a cell to transform into a cancer cell it must suffer a large number of mutations affecting different genes needed to control cell growth. In a study published this week in Science, Brandeis University researchers have found that the process of repairing DNA damage also unexpectedly increases the rate of mutations and changes the kinds of mutations that arise.

Surprisingly, as cells progress toward full-blown cancer they begin to suffer alterations of the normal DNA replication process, leading to an increased amount of DNA damage, especially chromosome breaks. Thus there is an increased need for cells to accurately repair these breaks.

Biologist James Haber, graduate student Wade Hicks and undergraduate Minlee Kim report that the repair of damaged strands of DNA, specifically by a process known as gene conversion, can cause higher-than-normal levels of mutation; in fact, 1,400 times as high as spontaneous mutations in cells.

"It has been hard to imagine how cells could accumulate so many mutations in the few generations that they undergo cell division on the way to becoming cancerous," Haber said. "We think that the elevated rate of mutation at sites where DNA has been broken may be an important source of these gene changes."

Most DNA damage takes the form of double-stranded DNA breaks (DSBs), for which the cell has multiple methods of self-repair. One method, gene conversion (GC), was originally believed to be relatively error-free, since it involves repairing the break by copying in DNA from a nearly identical sequence that serves as a library to restore the original DNA sequence.

"During repair, mutation rates increase, and the types of mutation during repair are different from normal mutagenesis, explained Hicks, the lead author. "It would be interesting to do an in depth analysis of the types of mutations in cancer cells and compare to those we observed in a repair event to see if they match up."

While other studies have looked at GCs and mutation rates in the past, this is the first study to look directly at the region where both DNA strands are replaced. The researchers used yeast cells, a simple organism in which it is possible to induce a single DSB at one location in all cells and then count the number of mutations that arise during the repair of the break. Through this simple system, Haber and his colleagues were able not only to measure the mutation rates, but also to determine which DNA repair enzymes are most important for GC, and to suggest a possible reason for the high number of mutations created.

They discovered that an innate repair system known as mismatch repair does not get recruited during GC; therefore mutations cannot be fixed. In addition, they discovered that many of the repair-associated mutations had a distinct "signature," which suggested that the copying of DNA that must occur during the repair of the break was frequently interrupted and required a way to "find the right place" to recommence copying. One striking consequence of the lack of straightforward copying was that some of the repair events involved "template switches," in which the copying machinery jumped from the template it was supposed to use to another, distantly related DNA sequence on another chromosome.

"The next steps for this project will be to better characterize these template switches we observed," said Hicks. "What is the actual rate of these events? What proteins are required or not to do the template switches?"

It will now be important to see if there is an acceleration of mutagenesis in precancerous mammalian cells and to learn if there are ways to prevent it from occurring.


Story Source:

The above story is based on materials provided by Brandeis University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wade M. Hicks, Minlee Kim, James E. Haber. Increased Mutagenesis and Unique Mutation Signature Associated with Mitotic Gene Conversion. Science, Vol. 329. no. 5987, pp. 82 - 85 DOI: 10.1126/science.1191125

Cite This Page:

Brandeis University. "DNA mutation rates raise curtain on cause of cancer." ScienceDaily. ScienceDaily, 1 July 2010. <www.sciencedaily.com/releases/2010/07/100701145529.htm>.
Brandeis University. (2010, July 1). DNA mutation rates raise curtain on cause of cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/07/100701145529.htm
Brandeis University. "DNA mutation rates raise curtain on cause of cancer." ScienceDaily. www.sciencedaily.com/releases/2010/07/100701145529.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins